Log In
BCIQ
Print this Print this
 

Sulfanegen

  Manage Alerts
Collapse Summary General Information
Company Vytacera Pharma Inc.
DescriptionAntidote for cyanide poisoning
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationPoisoning
Indication DetailsTreat cyanide poisoning
Regulatory Designation
PartnerUniversity of Minnesota

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/09/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today